跳至主要内容
临床试验/JPRN-UMIN000027596
JPRN-UMIN000027596已完成未知

A validation study to evaluate a novel cancer screening using C. elegans - A validation study to evaluate a novel cancer screening using C. elegans

Saitama Medical University International Medical Center0 个研究点目标入组 441 人开始时间: 2017年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
441

研究概览

简要总结

There were 95 noncancer cases and 104 pancreatic cancer cases. The sensitivity and specificity of N-NOSE for pancreatic cancer were 84.6% (88/104) and 60%(57/95), respectively. N-NOSE was able to detect stages 0 to I pancreatic cancer and had a higher correlation with early-stage pancreatic cancer than advanced stage.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. the one who can not obtain urine sample such as dyalysis patients

研究者

相似试验